CalciMedica, Inc.

CALC

CalciMedica, Inc.

CALC

Insider Sentiment (TTM):

Last Purchase:2026-06-25Last Sale:2025-07-25Shares Purchased (TTM):288,554Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:956,596Shares Outstanding:15,822,163Institutional Ownership Pct.:6.05%

Earnings Market Reaction:

Filing Date:2026-05-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	8	12	5	6	13	8	9	5	7	6	12	19
Short Term Investments	0	1	9	12	12	11	5	14	19	6	3	-
Restricted Cash	-	-	-	-	-	-	-	-	-	0	0	0
Prepaid Expense And Other Assets Current	0	0	1	1	0	0	1	1	1	0	1	1
Assets Held For Sale Not Part Of Disposal Group	0	0	-	-	-	0	-	-	-	-	-	-
Assets Current	9	14	15	19	25	20	16	20	27	12	15	20
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	-	-	-	-	-	-	-	-	-	0	0	0
Assets	9	14	15	19	25	20	16	21	27	12	16	20
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	2	1	1	2	2	2	2	2	2	1	1	2
Other Accrued Liabilities Current	1	0	1	1	1	1	1	1	2	1	1	1
Liabilities Current	5	4	4	3	4	4	4	4	4	4	4	4
Liabilities Other Than Lo…
Other Liabilities Current	-	-	-	-	-	-	-	-	-	0	0	0
Liabilities	10	20	15	13	14	5	7	7	10	4	4	4
Convertible Notes Payable	-	-	-	-	-	-	-	-	-	0	0	0
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Convertible Preferred Sto…
Additional Paid In Capital Common Stock	183	183	178	177	176	174	165	164	163	154	154	154
Retained Earnings Accumulated Deficit	-184	-189	-179	-171	-165	-160	-156	-150	-146	-146	-142	-137
Accumulated Other Comprehensive Income Loss Net Of…	-	0	0	-0	-0	0	0	-0	-0	0	-	-
Stockholders Equity	-1	-7	-0	6	11	14	9	14	17	8	12	16
Liabilities And Stockholders Equity	9	14	15	19	25	20	16	21	27	12	16	20
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Series A Convertible Preferred Stock	-	-	-	-	-	-	-	-	-	0	0	0
Common Stock Shares Authorized	5,000	5,000	5,000	5,000	5,000	5,000	5,000	5,000	5,000	5,000	5,000	5,000
Series B Convertible Preferred Stock	-	-	-	-	-	-	-	-	-	0	0	0
Series C1 Convertible Preferred Stock	-	-	-	-	-	-	-	-	-	0	0	0
Common Stock Shares Issued	63	62	57	56	56	54	54	54	54	58	57	57
Shares Outstanding	16	15	14	14	14	13	11	11	11	6	11	11
Series C2 Convertible Preferred Stock	-	-	-	-	-	-	-	-	-	0	0	0
Series D Convertible Preferred Stock	-	-	-	-	-	-	-	-	-	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	68.25%	53.17%	-	-	-	-	-	-	-	-	-	-
2025	-9.04%	-15.84%	53.69%	24.19%	29.03%	19.35%	30.84%	101.80%	-73.05%	-1.90%	0.86%	8.45%
2024	-1.73%	-18.46%	-13.27%	13.25%	-6.86%	-25.00%	-15.88%	-5.29%	-24.71%	-25.12%	-3.38%	-16.91%
2023	-	-	-	-1.65%	-18.60%	-31.76%	24.76%	-9.21%	76.83%	-3.37%	31.01%	17.31%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	1.61	3.58	4.04	5.45	5.66	5.34	4.15	5.22	6.21	2.88	4.14	4.98
Quick Ratio	1.59	3.51	3.89	5.27	5.61	5.27	3.86	4.89	6.00	2.81	3.96	4.74
Working Capital	3.24M	9.75M	11.17M	15.49M	20.76M	15.98M	11.90M	16.53M	22.32M	7.58M	11.59M	16.02M
Leverage & Debt
Debt to Equity	-8.80	-3.05	-56.65	2.13	1.33	0.37	0.80	0.52	0.57	0.49	0.30	0.25
Interest Coverage TTM	-17.18	-16.26	-22.71	-32.46	-55.78	-	-	-	-	-	-	-
Debt Ratio	1.13	1.49	1.02	0.68	0.57	0.27	0.44	0.34	0.36	0.33	0.23	0.20
Efficiency & Turnover
Asset Turnover TTM	0.04	0.04	0.05	0.04	0.03	0.06	0.05	0.03	0.01	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-1.20	-1.97	-1.53	-1.39	-1.34	-1.22	-1.22	-1.13	-1.49	-3.83	-2.54	-2.36
Free Cash Flow Per Share TTM	-1.34	-1.41	-1.41	-1.41	-1.51	-1.88	-1.78	-1.77	-2.58	-2.88	-2.32	-2.08
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-3,603.73%	-3,242.78%	-3,209.79%	-2,930.44%	-2,743.01%	-2,386.98%	-2,793.88%	-3,685.22%	-7,003.91%	-	-	-
Net Profit Margin TTM	-3,167.59%	-4,146.14%	-2,971.65%	-2,444.26%	-2,076.13%	-1,351.08%	-1,698.50%	-2,163.06%	-4,866.12%	-	-	-
Growth Metrics
Net Revenue Growth (1Y)	-32.12%	-29.68%	-3.00%	46.74%	196.09%	-	-	-	-	-	-	-
Net Income Growth (1Y)	3.56%	115.78%	69.71%	65.81%	26.33%	-60.12%	-52.81%	-52.95%	-36.38%	339.12%	60.72%	14.71%
EPS Growth (1Y)	-7.57%	61.65%	25.34%	23.06%	-12.74%	-68.19%	-51.96%	-52.13%	-24.85%	463.52%	65.07%	17.61%
Valuation Metrics
P/E TTM	-0.44	-3.35	-2.01	-1.15	-1.43	-2.91	-3.63	-3.50	-2.72	-0.75	-1.05	-1.70
P/B TTM	-7.74	-14.90	-173.04	3.93	2.48	2.76	5.46	3.18	2.35	3.15	2.48	2.80
P/S TTM	13.85	138.74	59.76	28.09	29.67	39.26	61.66	75.72	132.18	-	-	-
Market Cap	8.54M	98.92M	46.38M	23.99M	26.97M	39.81M	49.33M	44.07M	40.58M	25.66M	30.15M	45.41M
Enterprise Value	379.97K	87.40M	40.91M	18.07M	14.42M	31.88M	40.18M	39.02M	33.82M	20.13M	18.51M	26.32M
Calculated Values
Free Cash Flow TTM	-21.18M	-21.21M	-21.32M	-21.21M	-21.33M	-21.15M	-19.79M	-19.69M	-25.17M	-25.81M	-26.29M	-23.54M
Net Debt	-8.16M	-11.52M	-5.47M	-5.92M	-12.56M	-7.94M	-9.15M	-5.06M	-6.76M	-5.53M	-11.64M	-19.08M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-25Purchase

Owner: Middleton, Fred A

Title: -

Shares: 248,972

Price/Share: $0.80

Value: $199,177.60

Shares Owned: 1,063,272

Relationship: Director,TenPercentOwner

Ownership: Indirect

2025-09-18Purchase

Owner: Roberts, Eric W

Title: CHIEF BUSINESS OFFICER

Shares: 2,500

Price/Share: $3.07

Value: $7,675.00

Shares Owned: 84,150

Relationship: Director,Officer,TenPercentOwner

Ownership: Indirect

2025-09-15Purchase

Owner: Roberts, Eric W

Title: CHIEF BUSINESS OFFICER

Shares: 3,400

Price/Share: $2.68

Value: $9,112.00

Shares Owned: 81,650

Relationship: Director,Officer,TenPercentOwner

Ownership: Indirect

2025-09-12Purchase

Owner: Roberts, Eric W

Title: CHIEF BUSINESS OFFICER

Shares: 5,000

Price/Share: $3.12

Value: $15,600.00

Shares Owned: 78,250

Relationship: Director,Officer,TenPercentOwner

Ownership: Indirect

2025-09-09Purchase

Owner: Roberts, Eric W

Title: CHIEF BUSINESS OFFICER

Shares: 2,343

Price/Share: $3.15

Value: $7,380.45

Shares Owned: 73,250

Relationship: Director,Officer,TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-25	Middleton, Fred A	Director,TenPercentOwner	-	Indirect	Purchase	248,972	0.80	$199,177.60	1,063,272	4
2025-09-18	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	2,500	3.07	$7,675.00	84,150	4
2025-09-15	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	3,400	2.68	$9,112.00	81,650	4
2025-09-12	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	5,000	3.12	$15,600.00	78,250	4
2025-09-09	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	2,343	3.15	$7,380.45	73,250	4
2025-08-29	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	800	2.74	$2,192.00	70,907	4
2025-08-21	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	3,508	2.79	$9,787.32	60,907	4
2025-08-20	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	2,000	2.72	$5,440.00	57,399	4
2025-08-19	Hebbar, Sudarshan	Officer	Chief Medical Officer	Direct	Purchase	9,563	2.82	$26,967.66	61,539	4
2025-08-15	Hebbar, Sudarshan	Officer	Chief Medical Officer	Direct	Purchase	4,392	2.79	$12,253.68	51,976	4
2025-08-15	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	5,076	2.90	$14,720.40	54,399	4
2025-07-28	Stauderman, Kenneth A.	Officer	Chief Scientific Officer	Direct	Purchase	1,000	3.96	$3,960.00	12,944	4
2025-07-25	Stauderman, Kenneth A.	Officer	Chief Scientific Officer	Indirect	Sale	1,000	3.65	$3,650.00	0	4
2025-07-22	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	1,500	3.78	$5,670.00	49,323	4
2025-07-21	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	1,500	3.37	$5,055.00	47,823	4
2025-07-21	Leheny, A. Rachel	Director,Officer,TenPercentOwner	CHIEF EXECUTIVE OFFICER	Indirect	Purchase	1,000	3.40	$3,400.00	3,500	4
2025-07-18	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	2,000	2.88	$5,760.00	46,323	4
2025-07-18	Wilson, Robert N	Director	-	Direct	Purchase	4,500	2.87	$12,915.00	422,029	4
2025-07-14	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	6,500	2.43	$15,795.00	44,323	4
2025-07-14	Leheny, A. Rachel	Director,Officer,TenPercentOwner	CHIEF EXECUTIVE OFFICER	Indirect	Purchase	2,500	2.47	$6,175.00	2,500	4
2025-07-09	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	5,000	1.60	$8,000.00	37,823	4
2025-07-01	Stauderman, Kenneth A.	Officer	Chief Scientific Officer	Indirect	Purchase	1,000	1.85	$1,850.00	1,000	4
2025-06-26	Bardin, Stephen	Officer	Chief Financial Officer	Indirect	Purchase	2,000	1.50	$3,000.00	3,000	4
2025-06-26	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	4,500	1.44	$6,480.00	32,823	4
2025-06-11	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	5,000	1.85	$9,250.00	28,323	4
2025-06-06	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	5,000	1.78	$8,900.00	23,323	4
2025-05-30	Bardin, Stephen	Officer	Chief Financial Officer	Direct	Purchase	1,000	1.69	$1,690.00	41,000	4
2024-12-06	Middleton, Fred A	Director,TenPercentOwner	-	Direct	Purchase	4,800	2.65	$12,720.00	36,514	4
2024-11-01	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Direct	Purchase	53,333	3.75	$199,998.75	164,706	4
2024-11-01	Leheny, A. Rachel	Director,Officer,TenPercentOwner	CHIEF EXECUTIVE OFFICER	Direct	Purchase	20,000	3.75	$75,000.00	130,926	4
2024-11-01	Middleton, Fred A	Director,TenPercentOwner	-	Direct	Purchase	20,000	3.75	$75,000.00	31,714	4
2024-11-01	Sanderling, Venture Partn…	TenPercentOwner	-	Direct	Purchase	86,867	3.75	$325,751.25	814,300	4
2024-11-01	Wilson, Robert N	Director	-	Direct	Purchase	53,333	3.75	$199,998.75	417,529	4
2024-08-27	Leheny, A. Rachel	Director,Officer,TenPercentOwner	CHIEF EXECUTIVE OFFICER	Direct	Purchase	1,000	4.19	$4,190.00	110,926	4
2024-08-23	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	5,000	3.58	$17,900.00	46,894	4
2024-08-23	Wilson, Robert N	Director	-	Direct	Purchase	54,000	3.72	$200,880.00	364,196	4
2024-08-21	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	5,000	4.04	$20,200.00	44,894	4
2024-06-28	Wilson, Robert N	Director	-	Direct	Purchase	51,278	3.52	$180,498.56	310,196	4
2024-06-27	Wilson, Robert N	Director	-	Direct	Purchase	8,443	3.23	$27,270.89	258,918	4
2024-06-27	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	5,000	3.22	$16,100.00	10,223	4
2024-04-02	Roberts, Eric W	Director,Officer,TenPercentOwner	CHIEF BUSINESS OFFICER	Indirect	Purchase	3,254	3.90	$12,690.60	39,894	4
2024-01-23	Middleton, Fred A	Director,TenPercentOwner	-	Indirect	Purchase	679,384	3.70	$2,513,720.80	946,744	4
2024-01-23	Sanderling, Venture Partn…	TenPercentOwner	-	Direct	Purchase	243,356	3.70	$900,417.20	946,744	4
2023-12-11	Wilson, Robert N	Director	-	Direct	Purchase	506	3.30	$1,669.80	182,161	4
2023-11-07	Leheny, A. Rachel	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	2,000	3.34	$6,680.00	18,840	4
2023-11-06	Leheny, A. Rachel	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	2,440	3.12	$7,612.80	16,840	4
2023-11-06	Roberts, Eric W	Director,Officer,TenPercentOwner	Chief Business Officer	Indirect	Purchase	2,400	3.12	$7,488.00	35,894	4
2023-11-03	Hebbar, Sudarshan	Officer	Chief Medical Officer	Direct	Purchase	36,000	2.74	$98,640.00	46,000	4
2023-11-03	Roberts, Eric W	Director,Officer,TenPercentOwner	Chief Business Officer	Direct	Purchase	3,700	2.77	$10,249.00	20,287	4
2023-11-03	Leheny, A. Rachel	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	5,000	2.85	$14,250.00	14,400	4
2023-08-29	Roberts, Eric W	Director,Officer,TenPercentOwner	Chief Business Officer	Indirect	Purchase	223	3.02	$673.46	5,223	4/A
2023-08-25	Roberts, Eric W	Director,Officer,TenPercentOwner	Chief Business Officer	Indirect	Purchase	736	3.18	$2,340.48	5,000	4
2023-08-22	Roberts, Eric W	Director,Officer,TenPercentOwner	Chief Business Officer	Indirect	Purchase	714	3.27	$2,334.78	4,264	4
2023-06-26	Roberts, Eric W	Director,Officer,TenPercentOwner	Chief Business Officer	Direct	Purchase	1,200	3.70	$4,440.00	13,387	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

6.05%

Inst. Shares: 956,596

Shares Outstanding: 15,822,163

2025-12-31

24.35%

Inst. Shares: 3,655,018

Shares Outstanding: 15,011,321

2025-09-30

23.67%

Inst. Shares: 3,568,904

Shares Outstanding: 15,076,456

2025-06-30

24.85%

Inst. Shares: 3,726,254

Shares Outstanding: 14,995,404

2025-03-31

27.72%

Inst. Shares: 3,914,285

Shares Outstanding: 14,121,569

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	956,596	15,822,163	6.05%
2025-12-31	3,655,018	15,011,321	24.35%
2025-09-30	3,568,904	15,076,456	23.67%
2025-06-30	3,726,254	14,995,404	24.85%
2025-03-31	3,914,285	14,121,569	27.72%
2024-12-31	4,236,325	11,245,915	37.67%
2024-09-30	3,016,608	11,134,964	27.09%
2024-06-30	2,928,981	11,129,053	26.32%
2024-03-31	3,503,596	9,754,517	35.92%
2023-12-31	472,241	8,972,516	5.26%
2023-09-30	581,837	11,334,686	5.13%
2023-06-30	668,598	11,323,866	5.90%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

CalciMedica, Inc. (CALC) — SEC Financial Statements & Analysis

CalciMedica, Inc. (CALC) is a pharmaceutical preparations company, incorporated in DE. CalciMedica, Inc. trades on Nasdaq as: CALC. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), CalciMedica, Inc. reported a -32.12% year-over-year revenue growth, a Debt-to-Equity ratio of -8.80x, a Price-to-Sales (P/S) ratio of 13.85x (TTM), a Price-to-Book (P/B) ratio of -7.74 (TTM), at a market cap of $8.54M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -32.12%
Debt To Equity: -8.80x
P/S TTM: 13.85x
P/B TTM: -7.74
Market Cap: $8.54M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is CalciMedica, Inc. in?

CalciMedica, Inc. (CALC) operates in the Pharmaceutical Preparations industry.

What is CALC's market cap?

CalciMedica, Inc. (CALC) has a market capitalization of $8.54M as of 2026-03-31.

What exchange does CALC trade on?

CalciMedica, Inc. (CALC) trades on the Nasdaq.

Where is CalciMedica, Inc. incorporated?

CalciMedica, Inc. is incorporated in DE.

CalciMedica, Inc. (CALC) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.